Adult cases of visceral leishmaniasis (VL), predominantly males, have been reported in the past decade from natives of high altitude areas of North Indian state of Uttarakhand. We report 14 pediatric cases of VL, who were diagnosed and treated successfully over the past 7 years. All these children were born and brought up in this area and had never visited any of the endemic areas. High prevalence of pallor, splenohepatomegaly, thrombocytopenia and poor association with HIV are cardinal features of VL in this region. Although newer drugs have become available, the protozoan continues to be sensitive to sodium stibogluconate. We conclude that the transmission cycle of VL has been established in this region and VL should be considered in the differential diagnosis of any child presenting with fever and hepatosplenomegaly. However, molecular and epidemiological studies are needed to identify the ancestry, vector and animal reservoir if any in this region.
I N T R O D U C T I O N
Visceral leishmaniasis (VL), commonly known as kala-azar in Indian subcontinent, is a disease of poor people in Asia, Africa and Latin America. It is associated with malnutrition, human migration, poor housing, immunodeficiency and lack of resources [1] [2] [3] [4] . A recent review shows that >98 countries and territories are endemic for leishmaniasis. It is estimated that worldwide approximately 0.2-0.4 million new cases of VL occur each year. More than 90% of global burden of VL occur in six countries: Bangladesh, Brazil, Ethiopia, India, Nepal and South Sudan [5] . VL continues to be reported from India with 20,571 new cases reported in 2012 as per Global health observatory data [6] .
Vast majority of cases of VL in India occur in the eastern parts of the country, mainly Bihar, West Bengal, eastern Uttar Pradesh, Assam and the V C The Author [2016] . Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com foothills of Sikkim [2, 3] . VL is usually a disease of low altitude, up to 500 m above mean sea level (MSL). However, during past decade, cases are being reported from natives of high-altitude subHimalayan region of North India (Himachal Pradesh $2000-3000 m and Garhwal $1500-2500 m above MSL) [7] [8] [9] . All these reported cases are of adults, predominantly men with no pediatric case. Children usually constitute 50% cases of VL, but they along with women tend to be under reported [2, 3] . We are reporting epidemiological, clinico-laboratory and therapeutic features of pediatric VL from Garhwal region of Uttarakhand. This is the first study of pediatric VL from this high-altitude, non-endemic western Himalayan region of North India.
M E T H O D S
All children (<18 years) with VL consecutively diagnosed and treated at the single tertiary referral center of the Garhwal region of the North Indian state of Uttarakhand, presenting over the past 7 years were included in the study. The clinical and laboratory data were retrieved from the hospital records and the outcomes were ascertained from the hospital records and/or telephonic contact wherever possible. Analysis of the demographic, clinical and laboratory data was performed using descriptive statistics. All the patients were diagnosed on the basis of clinical features and bone marrow examination. VL was defined as identification of the amastigote form of leishmania (Leishmania donovani bodies also called as LD bodies) in bone marrow smears in a patient with clinical and laboratory features compatible with VL (i.e., fever, hepatosplenomegaly, anemia, leukopenia and thrombocytopenia). Splenic aspirate being invasive and potentially hazardous to children was not used. All cases were screened for tuberculosis and HIV infection. Clinical response was assessed at the completion of treatment and at follow up. Cure was defined as defervescence of fever, restoration of laboratory parameters, significant reduction in size of spleen and liver and lack of recurrence of symptoms during follow up.
R E S U L T S
Between August 2008 and July 2015, 14 pediatric cases of VL were diagnosed on the basis of compatible clinical and laboratory manifestations and presence of LD bodies on bone marrow smear examination and treated at this center. Additionally, four of these cases had a positive serological test with rK39 immunochromatographic strip. All these children were born and brought up in the Garhwal region of Uttarakhand and had never visited any of the endemic areas. The main presenting features were prolonged fever and the presence of splenohepatomegaly. The various clinical and laboratory features are shown in Table 1 .
Seven of these patients also had significant hemophagocytosis on bone marrow smear examination in addition to LD bodies. Additionally, five had hypertriglyceridemia and hyperferritinemia and fulfilled (six of the eight criteria) the criteria (minimum required five of the eight criteria) to be labeled as hemophagocytosis syndrome (HS) also known as hemophagocytic lymphohistiocytosis (HLH) [10] . All cases had negative screening test results for tuberculosis and HIV infection. All but one of these cases were treated with sodium stibogluconate (20 mg/ kg/day) intravenously for 4 weeks and were declared disease free on the basis of improvement in clinical features, reduction in size of spleen and liver and lack of recurrence of symptoms during follow up period ranging from 18 to 72 months. One child had presented with intracranial hemorrhage secondary to severe thrombocytopenia and succumbed to the disease even before the report of definitive bone marrow examination was available and treatment could be started. This child had significant hemophagocytosis in bone marrow smears.
D I S C U S S I O N
The high-altitude hilly Garhwal region of Uttarakhand can be considered as new emerging hot spot of VL in India, encouraging transmission of the protozoan. It is still not yet clear whether the parasite has come from a hereto unrecognized sylvatic cycle or introduced de novo by migrant population, although the latter appears more likely, as VL usually does not occur at this high altitude and there have been no reports of VL from this area till recently. The construction of the huge Tehri Dam and a number of hydroelectric power projects, initiated migration of skilled and manual laborers from the states of western Uttar Pradesh and Bihar which are endemic for VL. Subsequently improved road links, increased mobility and the ecological changes after these projects became functional have apparently caused an environmental shift in favor of vector proliferation, leading to an emergence and establishment of the disease in this region. Similar epidemiological factors have been implicated in emergence of VL at high-altitude areas of neighboring state of Himachal Pradesh [7, 8] . The fact that all our patients had contracted the disease indigenously, as all the 14 children were born and brought up in the Garhwal region of Uttarakhand and had never visited any of the endemic areas, is suggestive of establishment of a local transmission cycle with a local vector and probably an animal reservoir. This is a subject of future study, although existence of the vector, predominantly Phlebotomus argentipes, and a pocket of the disease in the adjacent Kumaon region has already been substantiated [11] .
Although clinical and laboratory profile of our patients was more or less classical, they had higher prevalence of pallor, lymphadenopathy, splenohepatomegaly, thrombocytopenia and hyperglobulinemia than reported in previous pediatric studies [12] .
An important distinguishing feature in our study was the finding of hemophagocytosis in bone marrow. Hemophagocytosis in bone marrow was seen in seven cases, and five (36%) of the patients fulfilled the clinical and laboratory criteria of HS [10] . HS is a systemic disease characterized by the overwhelming activation of normal T lymphocytes and macrophages, leading to clinical and hematologic alterations. Many of the clinical and laboratory features of this disorder (fever, hepatosplenomegaly, lymphadenopathy, pancytopenia, coagulopathy and abnormal liver enzymes) are indistinguishable from that of VL. The diagnosis of HS is established when at least five of eight criteria of HLH are present [10] . Primary HS is a hereditary disorder with autosomal recessive transmission that usually occurs during infancy. Secondary or reactive HS (RHS) occurs at any age after strong immunological activation induced by malignancies, autoimmune diseases and systemic infections. Viral infections, especially by epstein barr virus (EBV), represent the most frequent cause of RHS in children [13] . Less frequently, RHS can be secondary to bacterial, fungal and parasitic infections, including Leishmania. RHS secondary to VL is rare in childhood, with <50 cases reported in literature to date [14] [15] [16] [17] [18] . VL-associated RHS is associated with rapid progression and increased mortality if the underlying infection remains untreated [18, 19] . Further failure to recognize the underlying infection may lead to unnecessary cytotoxic therapy for primary HS. Thus, it is extremely important for the treating physician and hematologist to be aware of this association, as failure to recognize either can lead to deleterious consequences. The reasons for HS in kalaazar are not known; however, inappropriate activation of macrophages and T lymphocytes may be due to host immune activation, as nonspecific B cell activation and hyper-globulinemia are a common feature of VL. Another distinguishing feature in our study was lymphadenopathy, which was seen in five (36%) children. Lymphadenopathy is rare in Indian kalaazar, but is a common feature of Mediterranean kalaazar where it is seen in up to a third of children [12] . Four (80%) of these children had both lymphadenopathy and HS. This higher occurrence of lymphadenopathy in our children may be attributed to HS, as lymphadenopathy is a common feature of the latter.
The pentavalent antimonial drugs (sodium stibogluconate, meglumine antimoniate), given intravenously or intramuscularly for 3-4 weeks, are the most commonly used drugs to treat VL but high toxicity and treatment failures have been observed [20] . All our treated cases responded well to sodium stibogluconate, suggesting continuing sensitivity of the protozoan to this low-cost drugs. In recent times, there has been an increased reliance on Amphotericin B and oral drug Miltefosine for treatment over sodium stibogluconate. Low toxicity profile and shorter regimens have shifted treatment in their favor. Additionally, the dwindling demand of the antimony compounds has resulted in their reduced availability as well. Liposomal amphotericin B has emerged as the most effective and safest drug. Liposomal amphotericin B (3 mg/kg/day for five consecutive days, and two additional doses at days 14 and 21) demands a shorter period of administration than antimonial drugs. However, cost remains a limiting factor for resource-poor setting like ours. Conventional amphotericin B deoxycholate is also curative but can lead to many side effects such as renal toxicity. Pentamidine was previously considered the second-line drug in cases of pentavalent antimonial drug resistance, but certain toxicities (diabetes mellitus, gastrointestinal and cardiac side effects) and inferior cure rate to amphotericin B have been reported [18, 20, 21] . Nevertheless, our study suggests continuing sensitivity of the protozoan to low-cost drug sodium stibogluconate in this region.
C O N C L U S I O N VL is being increasingly diagnosed in the residents of high-altitude Garhwal region of the North Indian state of Uttarakhand. The protozoan seems to have got introduced into the area by migrant population from eastern parts of the country. However, molecular mapping is needed to establish the ancestry. As none of the children had ever ventured outside Garhwal region, the protozoan appears to have established a local transmission cycle, although local vector and probably an animal reservoir remain elusive. Epidemiological studies are needed to identify the vector and animal reservoir if any. High prevalence of pallor, splenohepatomegaly, thrombocytopenia, hyperglobulinemia, hemophagocytosis, sensitivity to sodium stibogluconate and negative HIV status are cardinal features of VL in this region.
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